Table 1 Demographic and clinical characteristics of 250 Xpert MTB/RIF-negative patients hospitalized at Jimma University Medical Center, Oromia, Ethiopia.

From: The value of lateral flow urine lipoarabinomannan assay and empirical treatment in Xpert MTB/RIF ultra negative patients with presumptive TB: a prospective cohort study

Characteristics

Category

All

Xpert ultra test results

Positive

Negative

Patients n

 

250

35

215

Age

≤ 40 years

144 (57.6)

29 (82.9)

115 (53.5)

> 40 years

106 (42.4)

6 (17.1)

100 (46.5)

Sex

Female

138 (55.2)

22 (62.9)

116 (54.0))

Male

112 (44.8)

13 (37.1)

99 (46.0)

Educational status

Illiterate

116 (46.4)

8 (22.9)

108 (50.2)

Primary level

51 (20.4)

8 (22.9)

43 (20.0)

Secondary & above

83 (33.2)

19 (54.2)

64 (29.8)

Residence

Urban

106 (42.4)

15 (42.9)

91 (42.3)

Rural

144 (57.6)

20 (57.1)

124 (57.7)

Health facilities visited prior to hospital admission

Local government hospitals

126 (50.4)

9 (25.7)

117 (54.4)

Primary care center

48 (19.2)

10 (28.6)

38 (17.7)

Private Clinic

58 (23.2)

13 (37.1)

45 (20.9)

None

18 (7.2)

3 (8.6)

15 (7.0)

Body mass index

≤ 18.5 kg/m2

84 (33.6)

22 (62.9)

62 (28.8)

> 18.5 kg/m2

166 (66.4)

13 (37.1)

153 (71.2)

HIV status

Negative

191 (76.4)

24 (68.8)

167 (77.7)

Positive

52 (20.8)

11 (31.4)

41 (19.1)

Unknown

7 (2.8)

0 (0.0)

7 (3.2)

CD4 count (n = 52)

≤ 200 cells/ml

24 (46.2)

10 (90.9)

14 (26.9)

> 200 cells/ml

28 (53.8)

1 (9.1)

27 (73.1)

History of TB treatment

No

205 (82.0)

27 (77.1)

178 (82.8)

Yes

45 (18.0)

8 (22.9)

37 (17.2)

Clinical severity

Non-severe

232 (92.8)

30 (85.7)

202 (94.0)

Severe

18 (7.2)

5 (13.9)

13 (6.0)

Weight loss

No

111 (44.4)

9 (25.7)

102 (47.4)

Yes

139 (55.6)

26 (74.3)

113 (52.6)

Pleuritic chest pain

No

82 (32.8)

5 (14.3)

77 (35.8)

Yes

168 (67.2)

30 (85.7)

138 (64.2)

Loss of appetite

No

49 (19.6)

2 (5.7)

47 (21.9)

Yes

201 (80.4)

33 (94.3)

168 (78.1)

Duration of cough

< 14 days

85 (34.0)

5 (14.3)

80 (37.2)

≥ 14 days

165 (66.0)

30 (85.7)

135 (62.8)

Duration of fever

< 14 days

137 (54.8)

17 (48.6)

120 (55.8)

≥ 14 days

113 (45.2)

18 (51.4)

95 (44.2)

Duration of night sweats

< 14 days

130 (52.0)

18 (51.4)

112 (52.1)

≥ 14 days

120 (48.0)

17 (48.6)

103 (47.9)

Duration of shortness of breath

< 14 days

123 (49.2)

10 (28.6)

113 (52.6)

≥ 14 days

127 (50.8)

25 (71.4)

102 (47.4)

  1. Data are presented as n (%), unless otherwise stated.